Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVianet Grp Regulatory News (VNET)

Share Price Information for Vianet Grp (VNET)

Share Price is delayed by 15 minutes
Get Live Data
69.50    0.50 (0.72%)
Bid:
67.00
Ask:
72.00
Spread: 5.00 (7.463%)
Market Cap: £19.76m
VNET Live PriceLast checked at - London Stock Exchange

Intraday Vianet Grp Share Chart

Form 8.3 - Brulines Group Plc

11 May 2010 08:16

RNS Number : 6822L
New Solera Holdings Limited
11 May 2010
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

New Solera Holdings Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Brulines Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

10 May 2010

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,469,500

5.26

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

1,469,500

5.26

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

 

25,000

GBP 1.22

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

11.05.2010

Contact name:

Ueli Dubendorfer

Telephone number:

+41 58 705 3209

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGGUAGAUPUUMG
Date   Source Headline
26th Oct 20227:00 amRNSTrading Update and Notice of Results
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 202210:49 amRNSDirector/PDMR Shareholding
16th Sep 20227:00 amRNSDirector/PDMR Shareholding
15th Sep 20229:50 amRNSDirector/PDMR Shareholding
4th Aug 20221:39 pmRNSDirector/PDMR Shareholdings
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSResult of AGM
13th Jul 20227:01 amRNSDirectorate Changes
13th Jul 20227:00 amRNSAGM Statement
22nd Jun 20227:00 amRNSVianet Wins Two Awards at ‘The Vendies’ 2022
14th Jun 20227:00 amRNSFinal Results
3rd May 20221:28 pmRNSHolding(s) in Company
28th Apr 20227:00 amRNSTrading Update and Notice of Results
29th Mar 20221:47 pmRNSHolding(s) in Company
28th Mar 20225:55 pmRNSTransaction in Own Shares
28th Mar 20228:40 amRNSTransaction in Own Shares
18th Mar 20225:16 pmRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20222:54 pmRNSTransaction in Own Shares
25th Feb 202211:47 amRNSPurchase of Own Shares - Correction
24th Feb 20225:57 pmRNSPurchase of own shares
22nd Feb 20222:27 pmRNSShare Buyback
11th Jan 20227:00 amRNSContract Announcement
7th Dec 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSTrading Update and Notice of Results
24th Aug 202110:56 amRNSExercise of Options
13th Jul 202111:28 amRNSResult of AGM
13th Jul 20217:00 amRNSAGM Statement
15th Jun 20217:00 amRNSFinal Results
14th Apr 20217:00 amRNSTrading and COVID-19 Update and Notice of Results
8th Mar 20213:25 pmRNSDirector/PDMR Shareholding
3rd Feb 202110:01 amRNSDirector/PDMR Shareholding
15th Jan 20213:15 pmRNSDirector/PDMR Shareholding
14th Jan 20212:46 pmRNSDirector/PDMR Shareholding
14th Jan 20212:11 pmRNSDirector/PDMR Shareholding
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20207:00 amRNSInterim Results
1st Dec 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSTrading Update and Notice of Interim Results
26th Aug 20207:00 amRNSTrading and COVID-19 Update
7th Aug 20202:40 pmRNSHolding(s) in Company
30th Jun 202011:30 amRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
2nd Jun 20207:00 amRNSFinal Results
30th Mar 20207:05 amRNSDirector/PDMR Shareholding
26th Mar 20207:00 amRNSTrading and COVID-19 Update and Notice of Results
17th Mar 202012:26 pmRNSDirector/PDMR Shareholding
12th Mar 202011:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.